Be aware of rapidly progressive ILD in pts w/high titer MDA5+ &⬆️ferritin. This patient had a clear CXR, but CT showed GGO. The patient decompensated w/in weeks. 2023 ACR guidelines for ILD Rx: https://t.co/E4lWuBXqvD
#dermatomyositis#RheumDermGR@JetPattersonMD@BrookeS_Mills
🚨2024-2025 Chief Residents alert!!🚨 So proud of this amazing group of physician leaders! We're incredibly fortunate to have you at UTSW IM & can't wait to see everything you'll accomplish🤩✨💙 @sharlenedong@MartinezZayasMd@JetPattersonMD @DinoKazi @dhjutsw1 @thomasjwang1
Excited to share the 1st paper of the International cSLE T2T Task Force, setting out a framework for T2T in cSLE. With fantastic teamwork and strong patient involvement I am confident we will achieve our goals and improve outcomes for cSLE! https://t.co/8mJoDg2esi
Top #SLE specific AVOIDABLE acute care conditions if high quality ambulatory care is received:
👉Vaccine preventable illnesses
👉Medication related complications
👉Reproductive health complications
👉SLE related comorbidities
Dr. C Feldman #RheumGR#HealthEquity#DEI
Can’t believe I lucked into working with @dhjutsw1 for a 2nd time! He’s always serving up medical wisdom (and fresh post-call doughnuts). Seeing Dr. @bkyalwazi in action is just inspiring, and we had two stellar students. The Seldin spirit is strong! 💪🏻
Join us in congratulating our categorical residents, physician-scientists, chief residents, and former residents who deferred fellowship training on successfully matching in their chosen subspecialties! @thomasjwang1 @DinoKazi @UTSWNews